Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aildenafil drug-drug interaction, alcohol interaction, nifedipine interaction, and multiple-dose pharmacokinetics study
ChiCTR2300071131Phase 4Recruiting
- Sponsor
- Peking University First Hospital
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of aildenafil in erectile dysfunction (ED) (11 arms), sponsored by Peking University First Hospital. Primary endpoints: Cmax, AUC0-t and 10 more. Started Sep 2022; status: recruiting.
02
Drugs
aildenafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on ChiCTR2300071131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300071131.